Evidence map›Paper›PMID 33900931›Full record

Trial reportJournal of medical Internet research2021

The Efficacy of Computerized Cognitive Behavioral Therapy for Depressive and Anxiety Symptoms in Patients With COVID-19: Randomized Controlled Trial.

Zhifen Liu, Dan Qiao, Yifan Xu, Wentao Zhao, Yang Yang, Dan Wen, Xinrong Li, Xiaoping Nie, Yongkang Dong, Shiyou Tang and 4 more

Open access · goldAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of medical Internet research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 8 pooled it
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 8 syntheses or guidelines pooled it, 170 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Non-Pharmacological Therapies for Post-Viral Syndromes, Including Long COVID: A Systematic Review.International journal of environmental research and public health · 2023
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. A digital intervention for cognitive deficits following COVID-19: a randomized clinical trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Trial
  13. Trial
  14. Trial
  15. Trial
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Zhifen LiuDepartment of Psychiatry, The First Hospital of Shanxi Medical University, Taiyuan, China.ORCID 0000-0003-0782-4195
Dan QiaoDepartment of Psychiatry, The First Hospital of Shanxi Medical University, Taiyuan, China.ORCID 0000-0001-5571-923X
Yifan XuDepartment of Psychiatry, The First Hospital of Shanxi Medical University, Taiyuan, China.ORCID 0000-0003-2617-4220
Wentao ZhaoDepartment of Psychiatry, The First Hospital of Shanxi Medical University, Taiyuan, China.ORCID 0000-0001-8015-5851
Yang YangDepartment of Psychiatry, The First Hospital of Shanxi Medical University, Taiyuan, China.ORCID 0000-0002-1880-1151
Dan WenDepartment of Psychiatry, The First Hospital of Shanxi Medical University, Taiyuan, China.ORCID 0000-0002-6484-6166
Xinrong LiDepartment of Psychiatry, The First Hospital of Shanxi Medical University, Taiyuan, China.ORCID 0000-0002-7138-8706
Xiaoping NieDepartment of Medical Service, Chongqing Public Health Medical Center, Chongqing, China.ORCID 0000-0002-6799-4906
Yongkang DongThe Fourth People's Hospital of Taiyuan, Taiyuan, China.ORCID 0000-0002-2066-0810
Shiyou TangDepartment of Psychiatry, Chongqing University Three Gorges Hospital, Chongqing, China.ORCID 0000-0002-0361-7714
Yi JiangDepartment of Respiratory and Critical Disease Medicine, The First Hospital of Shanxi Medical University, Taiyuan, China.ORCID 0000-0003-3680-9859
Ying WangDepartment of Geriatrics, The First Hospital of Shanxi Medical University, Taiyuan, China.ORCID 0000-0003-4785-070X
Juan ZhaoDepartment of Psychiatry, The First Hospital of Shanxi Medical University, Taiyuan, China.ORCID 0000-0002-6402-8278
Yong XuDepartment of Psychiatry, The First Hospital of Shanxi Medical University, Taiyuan, China.ORCID 0000-0001-9679-2273
Shanxi Medical University · CNChongqing University · CNThe Fourth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prevalence of depressive and anxiety symptoms in patients with COVID-19 is higher than usual. Previous studies have shown that there are drug-to-drug interactions between antiretroviral drugs and antidepressants. Therefore, an effective and safe treatment method was needed. Cognitive behavioral therapy (CBT) is the first-line psychological therapy in clinical treatment. Computerized CBT (cCBT) was proven to be an effective alternative to CBT and does not require face-to-face therapy between a therapist and the patient, which suited the COVID-19 pandemic response.

objectiveThis study aims to evaluate the efficacy of the cCBT program we developed in improving depressive and anxiety symptoms among patients with COVID-19.

methodsWe customized a cCBT program focused on improving depressive and anxiety symptoms among patients with COVID-19, and then, we assessed its effectiveness. Screening was based on symptoms of depression or anxiety for patients who scored ≥7 on the Hamilton Depression Rating Scale (HAMD

resultsThe cCBT + TAU group displayed a significantly decreased score on the HAMD

conclusionsThe findings of this study suggest that the cCBT program we developed was an effective nonpharmacological treatment for symptoms of anxiety, depression, and insomnia among patients with COVID-19. Further research is warranted to investigate the long-term effects of cCBT for symptoms of anxiety, depression, and insomnia in patients with COVID-19.

trial registrationChinese Clinical Trial Registry ChiCTR2000030084; http://www.chictr.org.cn/showprojen.aspx?proj=49952.

Indexed as

AdultAnxietyCognitive Behavioral TherapyCOVID-19DepressionFemaleHumansMalePandemicsProspective StudiesSARS-CoV-2anxietycCBTcomputerized cognitive behavioral therapyCOVID-19depressionmental healthtreatment

Identifiers

PMID33900931
PMCPMC8128049
OpenAlexW3159534035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.